Eyenovia
Open
$4.02
Prev. Close
$4.03
High
$4.02
Low
$4.02
Market Snapshot
$32.07M
-0.7
-61.88
$57.34K
13
Hyperion DeFi, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. The company is headquartered in New York City, New York and currently employs 13 full-time employees. The company went IPO on 2018-01-25. The firm is focused on providing simplified access to the Hyperliquid ecosystem. The company is also developing its proprietary Optejet User Filled Device (UFD) that is designed to work with a variety of topical ophthalmic liquids, including artificial tears and lens rewetting products. The Optejet is useful in chronic front-of-the-eye diseases due to its ease of use, enhanced safety and tolerability, and potential for superior compliance versus standard eye drops. Together, these benefits may result in higher treatment compliance and better outcomes for patients and providers. The company has launched its cryptocurrency treasury reserve, which is native to the decentralized digital asset exchange and Layer-1 blockchain, Hyperliquid. Hyperliquid is a layer one blockchain (L1) written and optimized from first principles.
emptyResult
Hyperion DeFi, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. The company is headquartered in New York City, New York and currently employs 13 full-time employees. The company went IPO on 2018-01-25. The firm is focused on providing simplified access to the Hyperliquid ecosystem. The company is also developing its proprietary Optejet User Filled Device (UFD) that is designed to work with a variety of topical ophthalmic liquids, including artificial tears and lens rewetting products. The Optejet is useful in chronic front-of-the-eye diseases due to its ease of use, enhanced safety and tolerability, and potential for superior compliance versus standard eye drops. Together, these benefits may result in higher treatment compliance and better outcomes for patients and providers. The company has launched its cryptocurrency treasury reserve, which is native to the decentralized digital asset exchange and Layer-1 blockchain, Hyperliquid. Hyperliquid is a layer one blockchain (L1) written and optimized from first principles.
Recently from Cashu
Eyenovia's Adaptive Strategies for Success in a Complex Ophthalmic Market Landscape
Eyenovia's Adaptive Strategies in a Divergent Market Landscape Eyenovia, a company focused on developing therapies for eye diseases and improving retinal health, demonstrates the importance of strateg…
Eyenovia: New Developments and Insights in the Biotechnology Sector
Please provide the text you would like summarized, and I will be happy to help!
Eyenovia: Summary of Key Developments and Future Prospects
Please provide the text you would like summarized, and I will be happy to help!
Eyenovia: Pioneering Innovative Ophthalmic Solutions in a Dynamic Market Landscape
Eyenovia's Focus on Innovative Ophthalmic Solutions Amidst Market Developments Eyenovia, a leader in developing novel ophthalmic therapies, is carving its niche in the eye care industry with its uniqu…